Humana reports third-quarter pretax income of $134 million

Reuters
Nov 05
Humana reports third-quarter pretax income of $134 million

Humana Inc. reported consolidated income before income taxes of $134 million for the third quarter of 2025, down from $651 million in the third quarter of 2024. For the nine months ended September 30, 2025, consolidated income before income taxes was $2,566 million, compared to $2,583 million for the same period in 2024. The results reflect the impact of the company's exit from the employer group commercial medical products business, as previously announced. Adjusted (non-GAAP) diluted earnings per share for full year 2025 are projected to be approximately $17.00, up from $16.21 reported for 2024. The company highlighted value creation initiatives and noted the effects of litigation settlements, business sales, and impairment charges on its financial results.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humana Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251105097506) on November 05, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10